Description: Tetra Bio-Pharma Inc., a development stage company, engages in the development of bio pharmaceuticals and natural health products containing cannabis and other medicinal plant based elements in Canada. The company offers Rx Princeps, a pharmaceutical-grade product based on its blend of smokable dried cannabis inhalation device. Its product pipeline includes PPP001, a dried cannabis prescription drug for advanced cancer pain; PPP002, a slow release formulation of Dronabinol for treating chemotherapy induced and chronic pain; PPP003, an ocular formulation of cannibinoids for the treatment of ocular pain and inflammation; PPP004, a topical cream for neuropathic pain; and PPP005, a cannabis oil capsule for the treatment of chronic pain. The company is also developing natural health products, including AGT001, a topical product for pain management; AGT002, an oral product line for cardiovascular disease prevention, athletic performance, and well-being; AGT003, a topical product for skin care; AGT004, a topical product for women; and Munchies B Gone gum. Tetra Bio-Pharma Inc. has a license and development agreement with IntelGenx Corp. for the development and commercialization of a drug product containing dronabinol; and Panag Pharma Inc. for the license and development of ocular and topical drugs. It also has research and development agreement with Constance Therapeutics, Inc. for the manufacture, process, prepare, study, research, and engage in clinical trials using the licensed products; co-development, marketing, and commercialization agreements with Neptune Technologies & Bioressources Inc. and Storz & Bickel; and strategic partnership with Sirius Air Solutions Inc. for suppling a specialized cannabis smoke air purifying system and a mask designed for law and emergency responders. The company was formerly known as GrowPros Cannabis Ventures Inc. and changed its name to Tetra Bio-Pharma Inc. in September 2016. Tetra Bio-Pharma Inc. is headquartered in Orleans, Canada.
Home Page: www.tetrabiopharma.com
2316 St. Joseph Boulevard
Orléans,
ON
K1C 1E8
Canada
Phone:
343 780 2020
Officers
| Name | Title |
|---|---|
| Dr. Guy Chamberland M.Sc., Master Herbal | Co-Founder, CEO, Chief Regulatory Officer & Director |
| Mr. Steeve Néron | Chief Commercial Officer |
| Mr. André Rancourt B.Sc. | Co-Founder |
| Ms. Leslie Auld CPA, M.B.A. | Chief Financial Officer |
| Dr. Melanie Edna Mary Kelly Ph.D. | Chief Scientific Officer |
| Jennifer McCaughey | VP of Investor Relations |
| Ms. Dania Scott B.Sc. | Sr. VP of Commercial Strategy |
| Ms. Aurelia De Pauw | Sr. VP of Clinical Programs & Medical Affairs |
| Mr. Richard Giguere | Chief Exec. Officer of Tetra Natural Health Inc. |
| Randy Ringuette | Project Director & Member of Advisory Board |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 48.196 |
| Price-to-Sales TTM: | 662.0967 |
| IPO Date: | |
| Fiscal Year End: | November |
| Full Time Employees: | 33 |